FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Glenmark Life Sciences IPO and Zomato IPO.
Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Zomato IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Glenmark Life Sciences IPO | Zomato IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Bofa Securities India Limited Bob Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Goldman Sachs (India) Securities Private Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited |
Bofa Securities India Limited Citigroup Global Markets India Private Limited Credit Suisse Securities (India) Private Limited Kotak Mahindra Capital Company Limited Morgan Stanley India Company Pvt Ltd |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Zomato IPO is up to ₹9,375.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Zomato IPO is ₹76.00 per share.
Glenmark Life Sciences IPO | Zomato IPO | |
---|---|---|
Face Value | ₹2 per share | ₹1 per share |
Issue Price (Lower) | ₹695.00 per share | ₹72.00 per share |
Issue Price (Upper) | ₹720.00 per share | ₹76.00 per share |
Issue Price (Final) | ₹720.00 per share | ₹76.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 20 shares | 195 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹1,060.00 Cr | up to ₹9,000.00 Cr |
OFS Issue Size | 63,00,000 shares | |
OFS Issue Size (Amount) | up to ₹453.60 Cr | up to ₹375.00 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹1,513.60 Cr | up to ₹9,375.00 Cr |
Glenmark Life Sciences IPO opens on Jul 27, 2021, while Zomato IPO opens on Jul 14, 2021. The closing date of Glenmark Life Sciences IPO and Zomato IPO is Jul 29, 2021, and Jul 16, 2021, respectively.
Glenmark Life Sciences IPO | Zomato IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jul 27, 2021 | Jul 14, 2021 |
Issue Close | Jul 29, 2021 | Jul 16, 2021 |
Basis Of Allotment (Tentative) | Aug 03, 2021 | Jul 22, 2021 |
Initiation of Refunds (Tentative) | Aug 04, 2021 | Jul 23, 2021 |
Credit of Share (Tentative) | Aug 05, 2021 | Jul 23, 2021 |
Listing date (Tentative) | Aug 06, 2021 | Jul 23, 2021 |
Anchor Lockin End date 1 | Sep 02, 2021 | Aug 21, 2021 |
Anchor Lockin End date 2 | Nov 01, 2021 | Oct 20, 2021 |
Glenmark Life Sciences IPO P/E ratio is , as compared to Zomato IPO P/E ratio of .
Glenmark Life Sciences IPO | Zomato IPO | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | |||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 82.84% | |||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in Zomato IPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 38,88,37,690 shares in Zomato IPO.
Glenmark Life Sciences IPO | Zomato IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 42,42,379 shares | 38,88,37,690 shares |
NII | 32,32,770 shares | 19,43,37,499 shares |
RII | 75,43,130 shares | 12,95,58,333 shares |
Employee | 0 shares | 65,00,000 shares |
Others | ||
Total | 1,50,18,279 shares | 71,92,33,522 shares |
Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Zomato IPO subscribed 38.25x.
Glenmark Life Sciences IPO | Zomato IPO | |
---|---|---|
QIB (times) | 36.97x | 51.79x |
NII (times) | 122.54x | 32.96x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 14.63x | 7.45x |
Employee (times) | 0.62x | |
Other (times) | ||
Total (times) | 44.17x | 38.25x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|